Limited cross-variant immunity from SARS-CoV-2 Omicron without vaccination


Por: Suryawanshi R.K., Chen I.P., Ma T., Syed A.M., Brazer N., Saldhi P., Simoneau C.R., Ciling A., Khalid M.M., Sreekumar B., Chen P.-Y., Kumar G.R., Montano M., Gascon R., Tsou C.-L., Garcia-Knight M.A., Sotomayor-Gonzalez A., Servellita V., Gliwa A., Nguyen J., Silva I., Milbes B., Kojima N., Hess V., Shacreaw M., Lopez L., Brobeck M., Turner F., Soveg F.W., George A.F., Fang X., Maishan M., Matthay M., Morris M.K., Wadford D., Hanson C., Greene W.C., Andino R., Spraggon L., Roan N.R., Chiu C.Y., Doudna J.A., Ott M.

Publicada: 1 ene 2022
Categoría: Multidisciplinary

Resumen:
SARS-CoV-2 Delta and Omicron are globally relevant variants of concern. Although individuals infected with Delta are at risk of developing severe lung disease, infection with Omicron often causes milder symptoms, especially in vaccinated individuals1,2. The question arises of whether widespread Omicron infections could lead to future cross-variant protection, accelerating the end of the pandemic. Here we show that without vaccination, infection with Omicron induces a limited humoral immune response in mice and humans. Sera from mice overexpressing the human ACE2 receptor and infected with Omicron neutralize only Omicron, but not other variants of concern, whereas broader cross-variant neutralization was observed after WA1 and Delta infections. Unlike WA1 and Delta, Omicron replicates to low levels in the lungs and brains of infected animals, leading to mild disease with reduced expression of pro-inflammatory cytokines and diminished activation of lung-resident T cells. Sera from individuals who were unvaccinated and infected with Omicron show the same limited neutralization of only Omicron itself. By contrast, Omicron breakthrough infections induce overall higher neutralization titres against all variants of concern. Our results demonstrate that Omicron infection enhances pre-existing immunity elicited by vaccines but, on its own, may not confer broad protection against non-Omicron variants in unvaccinated individuals. © 2022, The Author(s).

Filiaciones:
Gladstone Institutes, San Francisco, CA, United States
Biomedical Sciences Graduate Program, University of California, San Francisco, San Francisco, CA, United States
Department of Medicine, University of California, San Francisco, San Francisco, CA, United States
Quantitative Biosciences Institute COVID-19 Research Group, University of California, San Francisco, San Francisco, CA, United States
UCSF-Abbott Viral Diagnostics and Discovery Center, San Francisco, CA, United States
Innovative Genomics Institute, University of California, Berkeley, Berkeley, CA, United States
Department of Laboratory Medicine, University of California, San Francisco, San Francisco, CA, United States
Michael Hulton Center for HIV Cure Research at Gladstone, San Francisco, CA, United States
Department of Microbiology and Immunology, University of California, San Francisco, San Francisco, CA, United States
Curative Inc., San Dimas, CA, United States
Department of Medicine, University of California, Los Angeles, Los Angeles, CA, United States
Department of Urology, University of California, San Francisco, San Francisco, CA, United States
Department of Medicine, Cardiovascular Research Institute, University of California, San Francisco, San Francisco, CA, United States
Department of Anesthesia, Cardiovascular Research Institute, University of California, San Francisco, San Francisco, CA, United States
California Department of Public Health, Richmond, CA, United States
Chan Zuckerberg Biohub, San Francisco, CA, United States
Department of Molecular and Cell Biology, University of California, Berkeley, Berkeley, CA, United States
Molecular Biophysics and Integrated Bioimaging Division, Lawrence Berkeley National Laboratory, Berkeley, CA, United States
Howard Hughes Medical Institute, University of California, Berkeley, Berkeley, CA, United States
Department of Chemistry, University of California, Berkeley, Berkeley, CA, United States
California Institute for Quantitative Biosciences, University of California, Berkeley, Berkeley, CA, United States
ISSN: 00280836
Editorial
NATURE PUBLISHING GROUP, MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND, Reino Unido
Tipo de documento: Article
Volumen: 607 Número: 7918
Páginas: 351-355
WOS Id: 000818664500001
ID de PubMed: 35584773
imagen All Open Access, Hybrid Gold

MÉTRICAS